🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Antibody-dependent cell-mediated cytotoxicity (ADCC) is one of the importan...
Status
Unknown
Location
Shusen Wang
Start Date
2021-06-25
Trial ID
NCT04941885
Treatments Being Tested
This is a Phase 1, open-label study to evaluate the safety and the efficacy...
Status
Unknown
Location
Sun Yat-Sen University Cancer Center
Start Date
2021-07-28
Trial ID
NCT05016544
Treatments Being Tested
This study is a prospective, open, multi-center, single arm trial. The trea...
Status
Recruiting
Location
the First Affiliated Hospital of Wenzhou Medical University
Start Date
2021-11-27
Trial ID
NCT06234137
Treatments Being Tested
This study is designed to comprehensively evaluate the HER2 positive recurr...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-30
Trial ID
NCT06578299
Treatments Being Tested
This is a multi-center,randomized,phase 3 clinical trial. In the study, HER...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2021-02-02
Trial ID
NCT04736589
Treatments Being Tested
By measuring the intestinal flora abundance and bacterial count of patients...
Status
Unknown
Location
China
Start Date
2021-01-18
Trial ID
NCT05030519
Treatments Being Tested
A multicenter real-world study was conducted to gather clinicopathological ...
Status
Completed
Location
Liaoning Cancer Hospital &Institue
Start Date
2022-07-01
Trial ID
NCT06305702
Treatments Being Tested
To evaluate the efficacy and safety of inetetamab in combination with chemo...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02
Trial ID
NCT06818773
Treatments Being Tested
This is a prospective, no interventional, single arm cohort study, which ai...
Status
Recruiting
Location
Zhejiang Cancer Hospital
Start Date
2022-03-16
Trial ID
NCT05856383
Treatments Being Tested
Between July 2020 and August 2024, 301 HER2-positive MBC patients from five...
Status
Completed
Location
Fujian Cancer Hospital
Start Date
2020-07-01
Trial ID
NCT06990347
Treatments Being Tested